Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21

Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21
GALECTIN (NASDAQ: GALT) Delayed: 2.80 --0 (-0%)
Previous Close $2.80    52 Week High $3.05 
Open $2.80    52 Week Low $0.49 
Day High $2.80    P/E N/A 
Day Low $2.80    EPS $-1.32 
Volume